Meaghan Buisson News Today

A panel of top scientists has warned the FDA against approving MDMA for post-traumatic stress disorder (PTSD), despite widespread calls from campaigners to offer the party drug to sick patients.

Researchers warn of potential harms of psychedelic-assisted therapy as hype outstrips evidence.

A look inside the ‘shroom boom and the nascent Atlantic industry’s promise and perils.

Health Canada confirms reviews into trials following complaint of ‘alleged investigator misconduct’

A national drug policy advocacy organization is condemning how a prominent psychedelic research body responded to a B.C. woman’s allegations of sexual and physical abuse during clinical trials for MDMA-assisted psychotherapy.

The science of psychedelics is everywhere – but we should treat it with serious scepticism

Concerns about patient safety, reports of increased suicidal thinking and allegations of flawed research are at the heart of a new complaint to Health Canada over the much-hyped clinical trials for the use of MDMA to treat post-traumatic stress disorder.

In today's Morning Brief, we look at why Russia's military losses in its invasion of Ukraine are apparently so high.

Newly released videos that show two B.C. therapists cuddling, spooning, blindfolding and pinning down a distressed PTSD patient during clinical trials using MDMA have prompted a review of their work and fresh concerns about public safety.